# Relates to newborn screening for glucose-6-phosphate dehydrogenase deficiency

**Bill ID:** S6542
**Session:** 2023
**Sponsor:** Gustavo Rivera
**Status:** Vetoed

## Summary

Removes limitations on newborn screening for glucose-6-phosphate dehydrogenase deficiency.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  6542
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  April 26, 2023
  ___________
 
 Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to newborn  screening
  for glucose-6-phosphate dehydrogenase deficiency
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Paragraph (j) of subdivision 1 of  section  2500-a  of  the
 public  health  law,  as  amended  by chapter 70 of the laws of 2022, is
 amended to read as follows:
  (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative
 enzymatic test or other diagnostic test  in  cases  where:  the  newborn
 infant  presents with hemolytic anemia, hemolytic jaundice, or early-on-
 set increasing neonatal jaundice, that  is,  jaundice  (bilirubin  level
 greater than fortieth percentile for age in hours) persisting beyond the
 day  of  birth through the week after birth; the newborn infant has been
 admitted to the hospital for jaundice following birth; or the biological
 parent of the newborn infant indicates a family, racial, or ethnic  risk
 of  glucose-6-phosphate  dehydrogenase  deficiency,  including  having
 significant African, Asian, Mediterranean, or Middle Eastern ancestry].
  ยง 2. This act shall take effect immediately.
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD10869-02-3